Tuesday
Dec232008
Hormone replacement therapy and risk
Tuesday, December 23, 2008 at 16:17 SAN ANTONIO, Dec. 16 — The elevated breast cancer risk from hormone replacement therapy quickly dissipates after combined estrogen and progestin is discontinued, researchers reported here.










